Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Immunology
|
October 31, 2001
Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity
G P Geba, W Ptak, P W Askenase
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 20, 2010
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
C K Oh, G P Geba, N Molfino
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1991
Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine
W Ptak, G P Geba, P W Askenase
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1997
Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies
H Matsuda, H Ushio, G P Geba, et al.
The Journal of Experimental Medicine
|
February 1, 1996
Impaired primary T cell responses in L-selectin-deficient mice
J Xu, I S Grewal, G P Geba, et al.
The Journal of Clinical Investigation
|
February 15, 1996
Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness
O Einarsson, G P Geba, Z Zhu, et al.
The Journal of Experimental Medicine
|
October 9, 1998
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
U A Temann, G P Geba, J A Rankin, et al.
Immunological Investigations
|
April 30, 1998
Positive regulatory gamma delta T cells in contact sensitivity: augmented responses by in vivo treatment with anti-gamma delta monoclonal antibody, or anti-V gamma 5 or V delta 4
M Szczepanik, J Lewis, G P Geba, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 19, 2011
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor
N A Molfino, D Gossage, R Kolbeck, et al.
Contemporary Clinical Trials
|
September 22, 2010
Brain magnetic resonance imaging in adults with asthma
J Parker, L J Wolansky, D Khatry, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Immunology
|
October 31, 2001
Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity
G P Geba, W Ptak, P W Askenase
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 20, 2010
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
C K Oh, G P Geba, N Molfino
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1991
Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine
W Ptak, G P Geba, P W Askenase
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1997
Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies
H Matsuda, H Ushio, G P Geba, et al.
The Journal of Experimental Medicine
|
February 1, 1996
Impaired primary T cell responses in L-selectin-deficient mice
J Xu, I S Grewal, G P Geba, et al.
The Journal of Clinical Investigation
|
February 15, 1996
Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness
O Einarsson, G P Geba, Z Zhu, et al.
The Journal of Experimental Medicine
|
October 9, 1998
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
U A Temann, G P Geba, J A Rankin, et al.
Immunological Investigations
|
April 30, 1998
Positive regulatory gamma delta T cells in contact sensitivity: augmented responses by in vivo treatment with anti-gamma delta monoclonal antibody, or anti-V gamma 5 or V delta 4
M Szczepanik, J Lewis, G P Geba, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 19, 2011
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor
N A Molfino, D Gossage, R Kolbeck, et al.
Contemporary Clinical Trials
|
September 22, 2010
Brain magnetic resonance imaging in adults with asthma
J Parker, L J Wolansky, D Khatry, et al.
Page
of 3